-
公开(公告)号:US20110263657A1
公开(公告)日:2011-10-27
申请号:US13001145
申请日:2009-06-18
CPC分类号: A61K31/44
摘要: The present invention relates to pharmaceutical compositions for treating, preventing or managing heart failure and/or connected diseases therewith comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound.
摘要翻译: 本发明涉及用于治疗,预防或控制心力衰竭和/或与之相关的疾病的药物组合物,其包含任选与至少一种另外的治疗剂组合的至少二芳基脲化合物。 有用的组合包括例如 BAY 43-9006作为二芳基脲化合物。
-
公开(公告)号:US20110178137A1
公开(公告)日:2011-07-21
申请号:US13001193
申请日:2009-06-16
IPC分类号: A61K31/44 , C07D213/78 , A61P9/00
CPC分类号: A61K31/44
摘要: The present invention relates to pharmaceutical compositions and combinations for treating, preventing or managing heart failure and/or connected diseases therewith comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide optionally combined with at least one additional therapeutic agent.
摘要翻译: 本发明涉及用于治疗,预防或控制心力衰竭和/或相关疾病的药物组合物和组合,其包含4 {4- [3-(4-氯-3-三氟甲基苯基) - 脲基] -3-氟苯氧基} - 吡啶 -2-羧酸甲基酰胺任选地与至少一种另外的治疗剂组合。
-